drugset / Trial / NCT01687296
Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study to determine the efficacy and safety of nebulized fluticasone propionate 1mg twice daily compared with oral prednisone administered for 7 days to Chinese pediatric and adolescent subjects (aged 4 to 16 years) with an acute exacerbation of asthma
Timeline
- Start
- 2012-11-12
- Primary completion
- 2013-06-01
- Completion
- 2013-06-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 1 mg | Inhaled |
| Comparator | Prednisone | Other / unclassified | 1 mg/kg | Oral |
| Background | Salbutamol | Unknown | — | Inhaled |